Salmonella ve Salmonella'da Bulunan Antibiyotik Direnç Genlerinin Klinik ve Çevresel Örneklerden Hızlı Tespiti için Bakteriyofajların Genetik Olarak Tasarlanması


ŞEKER U. Ö. Ş. (Yürütücü)

TÜBİTAK Uluslararası İkili İşbirliği Projesi, 2555 - Gürcistan Shota Rustaveli Gürcü Ulusal Bilim Vakfı (SRGNSF) ile İkili İşbirliği Programı, 2026 - 2029

  • Proje Türü: TÜBİTAK Uluslararası İkili İşbirliği Projesi
  • Destek Programı: 2555 - Gürcistan Shota Rustaveli Gürcü Ulusal Bilim Vakfı (SRGNSF) ile İkili İşbirliği Programı
  • Başlama Tarihi: Ekim 2026
  • Bitiş Tarihi: Ekim 2029

Proje Özeti

i) Scientific/Technological Excellence

This project aims to develop a bacteriophage-based biosensor platform for the rapid, cost-effective, and amplification-free detection of Salmonella and its antibiotic-resistance genes in clinical and environmental samples. By leveraging genetically engineered bacteriophages, the platform will enable real-time, simultaneous detection of Salmonella and the presence of resistance markers, such as the bla (TEM-1) gene, through bioluminescence resonance energy transfer (BRET). The integration of luciferases coupled with RNA switches for Salmonella detection and resistance gene identification represents a significant advancement over traditional culture-based and molecular methods. This innovative approach eliminates the need for complex instrumentation, reduces detection time, and enhances accessibility for point-of-care and field applications, addressing critical gaps in public health surveillance and outbreak prevention.

ii) Methodology

The project involves isolating and characterizing Salmonella-specific bacteriophages, followed by genetic engineering to insert BRET-compatible luciferase reporter genes (firefly luciferase and renilla luciferase) into the phage genome. The firefly luciferase gene will be constitutively expressed to detect Salmonella, while the renilla luciferase gene will be regulated by a toehold RNA switch responsive to bla (TEM-1) mRNA, enabling selective detection of antibiotic resistance. Phage-host compatibility, adsorption rates, latent periods, and burst sizes will be optimized to ensure efficient infection and signal generation. CRISPR-Cas9-assisted recombineering will used for genetically modifying the native bacteriophages. Computational design of toehold switches will be employed to ensure precision and efficiency for antibiotic resistance identification. The engineered phages will be validated for limit of detection (LoD), sensitivity, and specificity in both laboratory and real-like matrices, including poultry farm boot swabs and human serum samples.

iii) Project Management

The project is structured into five key aims, each assigned to specialized teams to ensure efficient execution. The Georgian team will focus on phage isolation and characterization, while the Turkish team will handle the design and optimization of BRET-compatible luciferase fusion proteins, toehold RNA switches, and phage engineering. Regular progress reviews, data sharing, and collaborative problem-solving will be facilitated through virtual meetings and joint workshops. A detailed timeline with milestones and deliverables has been established to monitor progress and ensure timely completion. Risk management strategies, including contingency plans for technical challenges, have been developed to maintain project momentum.

iv) Importance of International Collaboration

This project brings together the expertise of researchers from Georgia and Turkey, combining their strengths in phage biology, synthetic biology, and biosensor development. The Georgian team’s extensive experience in phage isolation and characterization complements the Turkish team’s proficiency in genetic engineering and molecular diagnostics. This collaboration fosters knowledge exchange, enhances technical capabilities, and ensures the development of a robust and versatile detection platform. By pooling resources and expertise, the project benefits from diverse perspectives, accelerating innovation and increasing the likelihood of successful implementation in both countries and beyond.

v) Impact

The proposed bacteriophage-based biosensor platform has the potential to revolutionize the detection of Salmonella and antibiotic resistance, significantly improving public health outcomes. By providing a rapid, cost-effective, and easily deployable solution, the platform will enhance food safety, reduce the spread of antibiotic-resistant bacteria, and enable timely intervention during outbreaks. Technology’s adaptability allows for its extension to other bacterial pathogens, broadening its impact on global health. Furthermore, the project will strengthen scientific collaboration between Georgia and Turkey, fostering long-term partnerships and contributing to the advancement of biotechnology in the region. Ultimately, this innovation will support global efforts to combat antimicrobial resistance and improve infectious disease surveillance.